Back
Dyne Therapeutics Vs. Prime Medicine Industry Stock Comparison
Buy
59
DYN
Dyne Therapeutics
Last Price:
29.40
Seasonality Move:
18.56%
Buy
53
PRME
Prime Medicine
Last Price:
6.74
Seasonality Move:
-4.05%
Buy
59
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $28.16. The Score for DYN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Prime Medicine (PRME)
is a Buy
Is Prime Medicine a Buy, Sell or Hold?
- The current Prime Medicine [PRME] share price is $6.66. The Score for PRME is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PRME is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $28.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRME Stock Price Chart
What is Prime Medicine's stock price today?
-
The Prime Medicine share price today is $6.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRME is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 64.2 | Buy |
Chaikin Money Flow: | 470979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.52 - 26.62) | Buy |
Bollinger Bands (100): | (18.32 - 27.68) | Buy |
PRME Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 64.61 | Buy |
Chaikin Money Flow: | -540341 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.7 - 5.88) | Buy |
Bollinger Bands (100): | (5.62 - 8.4) | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.3 | Buy |
20-day SMA: | 25.45 | Buy |
50-day SMA: | 26.38 | Buy |
200-day SMA: | 16.47 | Buy |
8-day EMA: | 26.46 | Buy |
20-day EMA: | 26.02 | Buy |
50-day EMA: | 25.33 | Buy |
200-day EMA: | 19.07 | Buy |
PRME Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.79 | Buy |
20-day SMA: | 5.2 | Buy |
50-day SMA: | 6.17 | Buy |
200-day SMA: | 8.31 | Sell |
8-day EMA: | 5.89 | Buy |
20-day EMA: | 5.62 | Buy |
50-day EMA: | 6.05 | Buy |
200-day EMA: | 8.5 | Sell |
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.67 per share, and a decrease next year of $0.04 per share.
Prime Medicine Earnings Growth & PRME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.30 per share, and an increase next year of $0.10 per share.
Dyne Therapeutics Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Prime Medicine Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |